Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.
D000818:Animals; D002277:Carcinoma / Q000201:enzymology / Q000378:metabolism; D002460:Cell Line; D003853:Deoxyribonucleosides / Q000494:pharmacology; D003855:Deoxyribose / Q000378:metabolism; D003857:Deoxyuridine / Q000378:metabolism; D004357:Drug Synergism; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002955:Leucovorin / Q000494:pharmacology*; D051379:Mice; D012513:Sarcoma, Experimental / Q000201:enzymology / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
D003853:Deoxyribonucleosides; D003855:Deoxyribose; D007288:Inosine; D013940:Thymidylate Synthase; C012271:deoxyinosine; D002955:Leucovorin; D005472:Fluorouracil; D013936:Thymidine; D003857:Deoxyuridine